Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL)
currently treated remain scarce. We present an international analysis of 249 (United States …

Treating unfit patients with aggressive B-cell lymphoma poses the dilemma of balancing
potential cure while minimizing toxicity because of frailty and comorbidities. Age greater than …

Introduction. Prephase treatment (PP) is recommended in diffuse large B‐cell lymphomas
(DLBCL) to decrease therapy‐related toxicities and to avoid tumour lysis syndrome. Data in …

2 A. r. VArtANoV et AL. by national guidelines and primary evidence. A comprehensive list is
included in the supplemental methods. dose delays were assessed using iPtW logistic …

Background Tumor lysis syndrome (TLS) is a potentially life‐threatening condition resulting
from the rapid destruction of malignant cells, leading to electrolyte imbalances and severe …

Introduction Data on the optimal management of patients with hematologic malignancies
and chemotherapy-induced nausea and vomiting (CINV) are lacking, particularly for …

Clinical and Molecular Studies of Diffuse Large B-cell Lymphoma diva-portal.org Digitala
Vetenskapliga Arkivet Simple search Advanced search - Research publicationsAdvanced …

Tumor lysis syndrome (TLS) is a life-threatening condition caused by the rapid destruction of
malignant cells, leading to imbalances in electrolytes and posing risks such as acute kidney …

This study was conducted to investigate the efficacy of pre-phase therapy in preventing
tumor lysis syndrome (TLS) in cases with high tumor burden. This study involved 42 …

Abstract [eng] Introduction. Acute leukemia is the most common oncological disease in
children. Children with acute lymphoblastic leukemia may develop hyperleukocytosis (blood …